Editing cells in place: Targeted in vivo gene editing of hematopoietic stem cells
Traditional ex vivo hematopoietic stem cell (HSC) gene therapy faces manufacturing challenges.
Traditional ex vivo hematopoietic stem cell (HSC) gene therapy faces manufacturing challenges.